| Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico (NCT05041439) | Massachusetts General Hospital | 2021-07-06 |
| Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (NCT04033068) | Themis Bioscience GmbH | 2019-08-02 |
| Zika and Neurodevelopment Among Infants in Grenada (NCT04697147) | Windward Islands Research and Education Foundation | 2018-09-03 |
| Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) (NCT03624946) | Emergent BioSolutions | 2018-06-27 |
| ZIKAlliance Natural History Study (NCT03204409) | University of Heidelberg Medical Center | 2018-04-01 |
| Evaluation of the Clinical Performance of the ZIKV Detectâ„¢ 2.0 IgM Capture ELISA (NCT03776903) | InBios International, Inc. | 2018-04-01 |
| Applying Wolbachia to Eliminate Dengue (NCT03055585) | Gadjah Mada University | 2017-11-08 |
| Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (NCT03631719) | Universidad de Antioquia | 2017-10-25 |
| Safety and Immunogenicity of BBV121 (NCT04478656) | Bharat Biotech International Limited | 2017-06-03 |
| Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome (NCT03330600) | Universidade Federal de Pernambuco | 2017-06-01 |
| VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (NCT03110770) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-29 |
| Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection. (NCT03161444) | University Hospital Center of Martinique | 2017-03-21 |
| Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area (NCT03008122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-21 |
| A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. (NCT02963909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-11-01 |
| ZIKA Vaccine in Naive Subjects (NCT02952833) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-10-14 |
| Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus Infection (NCT03679728) | University of Sao Paulo | 2016-08-02 |
| Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF) (NCT03255369) | Oswaldo Cruz Foundation | 2016-01-02 |
| Neurologic Manifestations of the Arbovirus Infection in Colombia (NCT03206541) | Johns Hopkins University | 2016-01-01 |